Preview Mode Links will not work in preview mode

Keeping Current

Dec 31, 2025

Discover the patients who need timely treatment for metabolic dysfunction–associated steatohepatitis (MASH). How will you find them? And then what will you do?

Credit available for this activity expires: [12/30/26]
Earn Credit / Learning Objectives & Disclosures:


Dec 24, 2025

Alarming in immunoglobulin A nephropathy (IgAN): over 40% present late. Explore latest advancements in management of the most common cause of primary glomerulonephritis worldwide.

Credit available for this activity expires: 12/23/26
Earn Credit / Learning Objectives & Disclosures:


Dec 19, 2025

How well are you managing patients on EGFR inhibitor therapies in your clinical practice?

Credit available for this activity expires: 12/18/26
Earn Credit / Learning Objectives & Disclosures:


Dec 18, 2025

Learn from the experts about selecting the right BTK inhibitor therapy for patients with chronic lymphocytic leukaemia (CLL) in UK clinical practice.

Credit available for this activity expires: 12/16/26
Earn Credit / Learning Objectives & Disclosures: 


Dec 12, 2025

Did you know that, while well established in the metastatic setting, second-generation antibody-drug conjugates are now moving into the early setting?

Credit available for this activity expires: 12/10/26
Earn Credit / Learning Objectives & Disclosures: